DataMeds AI (MEDS) Retained Earnings (2023 - 2026)

DataMeds AI (MEDS) has reported Retained Earnings for 4 consecutive years, with -$118.8 million the latest figure, recorded in Q1 2026.

• For the quarter ending Q1 2026, Retained Earnings fell 354.55% year-over-year to -$118.8 million; the trailing twelve-month figure through Mar 2026 stood at -$118.8 million (down 354.55% YoY), and the FY2025 full-year result was -$111.0 million, down 773.47% from the prior year.
• Retained Earnings slipped to -$118.8 million in Q1 2026 per MEDS's latest filing, from -$111.0 million in the prior quarter.
• Across five years, Retained Earnings topped out at $89.9 million in Q3 2025 and bottomed at -$118.8 million in Q1 2026.
• Historically, Retained Earnings has averaged -$4.3 million across 4 years, with a median of $16.5 million in 2024.
• The sharpest annual moves came in 2024 and 2025: Retained Earnings jumped 668.32% in 2024, then tumbled 773.47% in 2025.
• Over 4 years, Retained Earnings stood at -$2.9 million in 2023, then surged by 668.32% to $16.5 million in 2024, then sank by 773.47% to -$111.0 million in 2025, then fell by 6.97% to -$118.8 million in 2026.
• According to Business Quant data, Retained Earnings over the past three periods registered -$118.8 million, -$111.0 million, and $89.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.